Literature DB >> 1717064

[In vitro effects of 24R,25-dihydroxyvitamin D3 on alkaline phosphatase and gamma-glutamyltransferase in the kidney of hypophysectomized rats].

M Prelot1, T X Do, A Giraul, A Thuillier.   

Abstract

The effects of 24R,25-dihydroxyvitamin D3 (24,25-(OH)2D3 on alkaline phosphatase (PAL), gamma-glutamyltransferase (GGT) and acid phosphatase (PAC) activities were investigated on renal cortex slices of hypophysectomized rats. Indeed after hypophysectomy renal 24,25-(OH)2D3 production was increased and renal PAL and GGT activities were decreased. After 5h incubation with physiological concentrations (0.1-10 nM) of 24,25-(OH)2D3 significant increases of PAL and GGT activities were produced. The maximum stimulation obtained with 1 nM was +23% for PAL and +26% for GGT as compared to controls. PAC was not modified. The time course of these effects was studied from 45 min to 8 h. In the presence of 24,25-(OH)2D3 (1 nM), delayed (3h) stimulation of PAL and GGT appeared. It reached the maximal value after 6h, +37% for PAL and +30% for GGT and persisted again at 8h. Cycloheximide added to incubation medium with steroid inhibited the stimulating effect on PAL only. Actinomycin D suppressed the induction of both enzymes, indicating that the observed actions of 24,25-(OH)2D3 depend on protein synthesis whose responsible mechanisms were different. These protein synthesis inhibitors did not modified enzymatic activities. Physiological significance of these renal effects is to be clarified.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1717064     DOI: 10.3109/13813459109146934

Source DB:  PubMed          Journal:  Arch Int Physiol Biochim Biophys        ISSN: 0778-3124


  1 in total

1.  1,25(OH)2 vitamin D3 signalling on immature rat Sertoli cells: gamma-glutamyl transpeptidase and glucose metabolism.

Authors:  Renata Gonçalves; Ariane Zamoner; Leila Zanatta; Ana Paula Zanatta; Aline Pertile Remor; Débora da Luz Scheffer; Alexandra Latini; Fátima Regina Mena Barreto Silva
Journal:  J Cell Commun Signal       Date:  2017-02-03       Impact factor: 5.782

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.